Trial Profile
A Phase 1 Study to Evaluate the Effect of Steady State Solifenacin and Mirabegron on the Steady State Pharmacokinetics of Tamsulosin HCl in Healthy Male Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 10 Sep 2016
Price :
$35
*
At a glance
- Drugs Mirabegron (Primary) ; Solifenacin (Primary) ; Tamsulosin (Primary)
- Indications Benign prostatic hyperplasia; Overactive bladder; Urination disorders
- Focus Pharmacokinetics
- Sponsors Astellas Pharma Europe Ltd
- 28 Aug 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 28 Jun 2014 New trial record